Finland· FI-REL-REL251
Algesal
A preparations with salicylic acid derivatives product containing diethylamine salicylate, registered in Finland by Solvay Pharma S.A.S.. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Diethylamine salicylate is registered in 8 of 19 countries.
Countries holding a registration under ATC M02AC (preparations with salicylic acid derivatives), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Diethylamine salicylate · ATC M02AC
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Diethylamine salicylate
- Manufacturer
- Solvay Pharma S.A.S.
- Country
- Finland (FI)
- ATC code
- M02AC
- ATC class
- Preparations with salicylic acid derivatives
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Diethylamine salicylate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Algofina
- United Kingdom (Northern Ireland) · Algesal, Odour Free Lloyds
- Hungary · Aciphen
- Portugal · Medalginan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/727125f5-9b19-4fc2-81c0-0b592feaf19f GET /v1/drugs/727125f5-9b19-4fc2-81c0-0b592feaf19f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "emulsiovoide",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "Salisyylihappojohdoksia sisältävät valmisteet",
"ma_number": "2274",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL251",
"authorised_at": "1965-09-29"
}See everything about diethylamine salicylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.